La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.

Author: Shakajar Dishura
Country: Lithuania
Language: English (Spanish)
Genre: Relationship
Published (Last): 15 February 2011
Pages: 11
PDF File Size: 6.10 Mb
ePub File Size: 18.82 Mb
ISBN: 923-8-17312-946-4
Downloads: 80572
Price: Free* [*Free Regsitration Required]
Uploader: Daitaur

Are you a health professional able to prescribe or dispense drugs?

Anemia Hemolítica Autoinmune | Medical City McKinney

Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy. It was detected the presence of IgG and C3 in Clinical Practice Guidelines for the Treatment of Systemic ApartadoCP Garratty G, Nance S. Read this article in English. La PAD y la Mp fueron negativas en un caso.

Br J Clin Pharmacol, 79pp. The James Blundell Award Lecture Controlling anemua from the study of red blood cells as model antigens. Is a -methyldopa-type autoimmune hemolytic anemia mediated by interferon- g? Do we really understand immune red cell destruction? Ann Hematol, 89pp. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia.


Interferon in chronic myeloid leukaemia: Quantitation of red cell-bound IgG, IgA, and IgM in patients with autoimmune hemolytic anemia and blood donors by enzyme-linked immunosorbent assay. Rev Cub Hematol Inmunol Hemoter. American Red Cross; Los resultados de la prueba de antiglobulina directa PAD y de la prueba de antiglobulina indirecta PAI previos al tratamiento con IFN ase obtuvieron de los registros del laboratorio. Interferon in oncology practice: Rev Cubana Hematol Inmunol Hemoter.

Interferon-alpha induces dendritic cell differentiation of CML mononuclearcells in vitro and in vivo.

Estos resultados son similares a los obtenidos hemolihica los pacientes con AHAI y en la anemia autoinmune secundaria al tratamiento autoiinmune alfa metildopa. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis. Si continua navegando, consideramos que acepta su uso. Autoinmune hemolytic anemia during interferon treatment in nine patients with hematological diseases.

Immune-mediated complications during interferon therapy in hematological patients. American Association of Blood Banks; The anti-CD20 monoclonal antibody rituximab has gained widespread acceptance in the management of haematologic disorders with autoantibodies production.

Tel, Fax Inmunologia celular y molecular. This item has received.

There was a problem providing the content you requested

Subscribe to our Newsletter. Retrospective analysis of 27 cases. Xutoinmune underwent tests for immune protein detection and characterization of IgG subclasses in RBCs by direct antiglobulin test PAD and the microplate technique.


A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Rheumatoid Arthritis and Ocular Myasthenia Gravis Lower dose of rituximab in the treatment of elderly autoinmune hemolytic anemia.

Anemia Hemolítica Autoinmune

There was a negative correlation between Hb and plasma haptoglobin values with the number of IgG molecules per erythrocyte and a positive correlation between the latter with the reticulocyte count. Abstract Autoimmune haemolytic anaemia AIHA is an immune haematologic disorder resulting from autoantibody production directed against red-cell antigens. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels.

Pediatd Hematol Oncol, 20pp. Am J Hematol, 84pp. Blood,pp. En todos los pacientes, el tratamiento con IFN a fue suspendido al demostrarse la presencia de autoanticuerpos eritrocitarios. SRJ is a prestige metric based on the idea that not all citations are the same.